London, England, United Kingdom Among the most successful fund investment fields, there are Robotics, Content Marketing. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sparrho, LabGenius.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Beast Ventures, startups are often financed by Pitch@Palace, Entrepreneur First. The meaningful sponsors for the fund in investment in the same round are Tom McInerney, Tiny Super Computer Investment Company, System.One. In the next rounds fund is usually obtained by iNovia Capital, Thirty Five Ventures, Sea Lane Ventures.
The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2017.
Besides them, we counted 2 critical employees of this fund in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Bopa Moruo | Sandston, United States, Virginia |
| GE32 Capital | Brazil, São Paulo, Sao Paulo |
| IGM Financial | Canada, Manitoba, Winnipeg |
| Interlink Ventures | Bavaria, Germany, Wörthsee |
| JHD | - |
| Ohio Innovation Fund | Columbus, Ohio, United States |
| QLogic | Aliso Viejo, California, United States |
| Sikepu Yiliao | Changsha, China, Jiangsu |
| Softbank UK Ventures | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Baseimmune | $12M | 26 Feb 2024 | London, England, United Kingdom | ||
Nutropy | $2M | 11 Sep 2022 | Bourgogne, Bourgogne-Franche-Comté, France | ||
Baseimmune | $4M | 02 Nov 2021 | London, England, United Kingdom | ||
Q Bio | $40M | 20 Feb 2020 | California, United States | ||
LabGenius | $3M | 24 Nov 2017 | London, England, United Kingdom | ||
Q Bio | $7M | 01 Jan 2016 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Baseimmune | $12M | 26 Feb 2024 | London, England, United Kingdom | ||
Nutropy | $2M | 11 Sep 2022 | Bourgogne, Bourgogne-Franche-Comté, France | ||
Baseimmune | $4M | 02 Nov 2021 | London, England, United Kingdom | ||
Q Bio | $40M | 20 Feb 2020 | California, United States | ||
LabGenius | $3M | 24 Nov 2017 | London, England, United Kingdom | ||
Q Bio | $7M | 01 Jan 2016 | California, United States |
